FIELD: medicine.
SUBSTANCE: invention relates to treatment of osteoporosis. Disclosed is the use of agent containing from 10 to 200 mg of diacerein, from 200 to 1000 mg of chondroitin and from 200 to 1000 mg of glucosamine for treating osteoporosis.
EFFECT: invention enables cartilage regeneration.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED AGENT BASED ON NSIAD, MUSCLE RELAXANT AND VITAMIN | 2017 |
|
RU2711624C2 |
| METHOD FOR CARTILAGE REGENERATION | 2007 |
|
RU2347559C1 |
| METHOD FOR TREATING PATIENTS FOR DEGENERATIVE DYSTROPHY DISEASES OF LOCOMOTOR APPARATUS AND POST-TRAUMATIC COMMISSURE PROCESSES | 2006 |
|
RU2299733C1 |
| PHARMACEUTICAL COMPOSITION, AGENT (VERSIONS) AND METHOD OF PREVENTING AND TREATING ARTHRITIS, OSTEOARTHROSIS AND VERTEBRAL OSTEOCHONDROSIS (VERSIONS) | 2012 |
|
RU2496511C1 |
| AGENT FOR CARE OF PERIPHERAL JOINTS AND BACKBONE AREA | 2008 |
|
RU2376011C1 |
| METHOD FOR PREVENTING AND TREATING ARTHROPATHIES AND METHODS FOR USING SAME | 2013 |
|
RU2521973C1 |
| METHOD OF TREATING LUMBAR OSTEOCHONDROSIS WITH ACCOMPANYING OSTEOARTHROSIS | 2009 |
|
RU2411025C1 |
| CHONDROITIN SULFATE SOLUTION FOR INTRAMUSCULAR ADMINISTRATION AND METHOD FOR ITS PREPARATION | 2015 |
|
RU2623050C2 |
| COMBINED AGENT FOR INTRAARTICULAR ADMINISTRATION | 2017 |
|
RU2737380C2 |
| METHOD FOR TREATING PATIENTS FOR DEGENERATIVE LOCOMOTOR APPARATUS DISEASES AND POSTTRAUMATIC PAIN SYNDROMES | 2004 |
|
RU2274472C1 |
